BioNexus Gene Lab Corp. (BGLC) NASDAQ
1.98
+0(+0.25%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.98
+0(+0.25%)
Currency In USD
| Market Cap | 7.33M |
| Enterprise Value | 5.13M |
| P/E Ratio | -1.23 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 0.5 |
| Price/Book Ratio | 0.43 |
| Enterprise/Revenue | 0.2 |
| Enterprise/EBITDA | -0.53 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.4 |
| Operating Margin | -0.4 |
| Return On Assets | -0.32 |
| Return On Equity | -0.39 |
| Revenue | 7.42M |
| Revenue/Share | 4 |
| Gross Profit | 1.09M |
| EBITDA | -2.8M |
| Net Income | -2.98M |
| Diluted EPS | -1.61 |
| Total Cash | 2.38M |
| Total Cash/Share | 1.28 |
| Total Debt | 176,046 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 10.46 |
| Book Value Per Share | 4.64 |
| 52-Week Change | -34.87 |
| 52-Week High | 15.6 |
| 52-Week Low | 1.92 |
| Moving Average 50 Days | 2.25 |
| Moving Average 200 Days | 3.91 |
| Average Volume | 5,735 |
| Shares Outstanding | 1.86M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.01 |
| Last Split Factor | 1:10 |
| Last Split Date | April 07, 2025 |